Isabel Barroeta

2.3k total citations · 1 hit paper
24 papers, 453 citations indexed

About

Isabel Barroeta is a scholar working on Public Health, Environmental and Occupational Health, Psychiatry and Mental health and Geriatrics and Gerontology. According to data from OpenAlex, Isabel Barroeta has authored 24 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Public Health, Environmental and Occupational Health, 9 papers in Psychiatry and Mental health and 8 papers in Geriatrics and Gerontology. Recurrent topics in Isabel Barroeta's work include Down syndrome and intellectual disability research (14 papers), Dementia and Cognitive Impairment Research (9 papers) and Frailty in Older Adults (8 papers). Isabel Barroeta is often cited by papers focused on Down syndrome and intellectual disability research (14 papers), Dementia and Cognitive Impairment Research (9 papers) and Frailty in Older Adults (8 papers). Isabel Barroeta collaborates with scholars based in Spain, United States and France. Isabel Barroeta's co-authors include Juan Fortea, María Carmona‐Iragui, Alberto Lleó, Laura Videla, Bessy Benejam, Tadafumi Hashimoto, Eloïse Hudry, Susana Fernández, Mireia Coma and Daniel Alcolea and has published in prestigious journals such as Neurology, Diabetes Care and Annals of Neurology.

In The Last Decade

Isabel Barroeta

18 papers receiving 447 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnostic performance of plasma pTau217, pTau181, Aβ1-42 and Aβ1-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease

2024 48 citations Javier Arranz, Nuole Zhu et al. Alzheimer s Research & Therapy profile →

Peers

Isabel Barroeta

PHYSI

PMH

PHEOH

CMN

Randolph D. Andrews United States

Laura Videla Spain

Lisi Flores Aguilar United States

Benoît Souchet France

Nazaret Gamez United States

Arthur Kay United States

Miharu Samuraki Japan

S. Cammarata Italy

Isabel Hernández Spain

Lewis Hutfles United States

Randolph D. Andrews United States

Isabel Barroeta

230 ×1.1

PHYSI

99 ×0.8

125 ×1.1

PMH

130 ×1.1

PHEOH

59 ×0.7

CMN

Citations per year, relative to Isabel Barroeta Isabel Barroeta (= 1×) peers Randolph D. Andrews

Countries citing papers authored by Isabel Barroeta

Since Specialization

Citations

This map shows the geographic impact of Isabel Barroeta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Barroeta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Barroeta more than expected).

Fields of papers citing papers by Isabel Barroeta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Barroeta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Barroeta. The network helps show where Isabel Barroeta may publish in the future.

Co-authorship network of co-authors of Isabel Barroeta

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Barroeta. A scholar is included among the top collaborators of Isabel Barroeta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Barroeta. Isabel Barroeta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Arranz, Javier, Nuole Zhu, Sara Rubio‐Guerra, et al.. (2025). Prospective evaluation of plasma pTau217 stability for the detection of Alzheimer’s disease in a tertiary memory clinic. Alzheimer s Research & Therapy. 17(1). 150–150.

Kac, Przemysław R., Daniel Alcolea, Laia Montoliu‐Gaya, et al.. (2025). Plasma p‐tau212 as a biomarker of sporadic and Down syndrome Alzheimer's disease. Alzheimer s & Dementia. 21(4). e70172–e70172. 3 indexed citations

Rafii, Michael S., et al.. (2025). Down syndrome and Alzheimer's disease: insights into biomarkers, clinical symptoms, and pathology. The Lancet Neurology. 24(9). 753–762. 3 indexed citations

Ledreux, Aurélie, María Carmona‐Iragui, Laura Videla, et al.. (2025). Cargo of small extracellular vesicles from neuronal origin shows progression of dementia in individuals with Down syndrome. Alzheimer s & Dementia. 21(6). e70380–e70380.

Arranz, Javier, Nuole Zhu, Sara Rubio‐Guerra, et al.. (2024). Diagnostic performance of plasma pTau217, pTau181, Aβ1-42 and Aβ1-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease. Alzheimer s Research & Therapy. 16(1). 139–139. 48 indexed citations breakdown →

Alcolea, Daniel, Laia Montoliu‐Gaya, María Carmona‐Iragui, et al.. (2024). Longitudinal plasma and CSF analyses in Down syndrome. Results from the DABNI cohort. Alzheimer s & Dementia. 20(S2).

Benejam, Bessy, Lídia Vaqué‐Alcázar, Valle Camacho, et al.. (2024). Posterior Cortical Atrophy Due to Alzheimer Disease in a Person With Down Syndrome. Neurology. 104(1). e210179–e210179. 1 indexed citations

Aldecoa, Ibán, Isabel Barroeta, Steven L. Carroll, et al.. (2024). Down Syndrome Biobank Consortium: A perspective. Alzheimer s & Dementia. 20(3). 2262–2272. 8 indexed citations

Pané, Adriana, Laura Videla, Judith Viaplana, et al.. (2024). Hypothalamic Inflammation Improves Through Bariatric Surgery, and Hypothalamic Volume Predicts Short-Term Weight Loss Response in Adults With or Without Type 2 Diabetes. Diabetes Care. 47(7). 1162–1170. 3 indexed citations

10.

Vaqué‐Alcázar, Lídia, María Carmona‐Iragui, Laura Videla, et al.. (2023). Cognitive reserve in Down syndrome: a new opportunity to understand resilience in Alzheimer’s disease. Alzheimer s & Dementia. 19(S23).

11.

Pegueroles, Jordi, Valle Camacho, Víctor Montal, et al.. (2023). [18F]PI2620 tau deposition increases along the Alzheimer’s disease continuum in Down Syndrome and in presence of amyloid. Alzheimer s & Dementia. 19(S21). 1 indexed citations

12.

Belbin, Olivia, M. Florencia Iulita, Laura Videla, et al.. (2023). Biofluid markers of Alzheimer’s disease‐associated CNS inflammation in adults with Down syndrome. Alzheimer s & Dementia. 19(S14).

13.

Giménez, Sandra, Laura Videla, Marta Gutiérrez‐Valencia, et al.. (2022). Feasibility and Long-Term Compliance to Continuous Positive Airway Pressure Treatment in Adults With Down Syndrome, a Genetic Form of Alzheimer’s Disease. Frontiers in Neuroscience. 16. 838412–838412. 2 indexed citations

14.

Montal, Víctor, Isabel Barroeta, Alexandre Bejanin, et al.. (2021). Metabolite Signature of Alzheimer's Disease in Adults with Down Syndrome. Annals of Neurology. 90(3). 407–416. 10 indexed citations

15.

Benejam, Bessy, Laura Videla, Eduard Vilaplana, et al.. (2020). Diagnosis of prodromal and Alzheimer's disease dementia in adults with Down syndrome using neuropsychological tests. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 12(1). e12047–e12047. 31 indexed citations

16.

Gonzalo‐Calvo, David de, Isabel Barroeta, María Carmona‐Iragui, et al.. (2020). Evaluation of biochemical and hematological parameters in adults with Down syndrome. Scientific Reports. 10(1). 13755–13755. 3 indexed citations

17.

Belbin, Olivia, Desheng Xu, María Carmona‐Iragui, et al.. (2020). Cerebrospinal fluid profile of NPTX2 supports role of Alzheimer’s disease-related inhibitory circuit dysfunction in adults with Down syndrome. Molecular Neurodegeneration. 15(1). 46–46. 24 indexed citations

18.

Fortea, Juan, María Carmona‐Iragui, Bessy Benejam, et al.. (2018). Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study. The Lancet Neurology. 17(10). 860–869. 124 indexed citations

19.

Sintas, Cèlia, Noèlia Fernàndez‐Castillo, Roser Corominas, et al.. (2017). Mutation Spectrum in the CACNA1A Gene in 49 Patients with Episodic Ataxia. Scientific Reports. 7(1). 2514–2514. 37 indexed citations

20.

Coma, Mireia, Beatriz Gomez Perez‐Nievas, Tadafumi Hashimoto, et al.. (2011). Activation of glycogen synthase kinase-3 beta mediates β-amyloid induced neuritic damage in Alzheimer's disease. Neurobiology of Disease. 45(1). 425–437. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact